Scientists test 'One-Time' gene fix for devastating childhood disease

NCT ID NCT05665166

Summary

This is a first-in-human safety study testing a new gene therapy for young boys with a severe form of Hunter syndrome, a rare genetic disorder. Researchers will collect a child's own stem cells, add a working copy of a missing gene in the lab, and return the cells to the child's body. The goal is to see if the body can then produce the missing enzyme itself, which may help treat symptoms, including those affecting the brain. Five young patients will be closely followed for at least two years to check safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUCOPOLYSACCHARIDOSIS II are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Manchester University Foundation Trust

    Manchester, United Kingdom

Conditions

Explore the condition pages connected to this study.